资讯
Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the US Food and Drug Administration (FDA) ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
10 小时
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Expanded Use of RSV Vaccine ArexvyGSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...
F or the past 60 years, a committee of independent experts has advised the federal government on vaccine policy, providing ...
REGINA, SK / ACCESS Newswire / June 16, 2025 / Shawn’s Property Management Ltd., a trusted name in property management since ...
REGINA, SASKATCHEWAN / ACCESS Newswire / June 16, 2025 / Consumer Choice Award (CCA) is proud to announce that Affordable ...
Planning Underway for Expedited Follow-up RC and Diamond Programs HIGHLIGHTS 2,882m reverse circulation (RC) drilling ...
LONDON, UK AND VANCOUVER, BC / ACCESS Newswire / June 16, 2025 / Mkango Resources Ltd. (AIM:MKA)(TSX-V:MKA) (“Mkango”) and CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec”) are pleased to provide ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果